Biotech

All Articles

Biogen cans SAGE-324 partnership after crucial shake stop working

.Biogen has provided the last ceremonies to its own cooperation with Sage Therapies on SAGE-324, scr...

AbbVie Parkinson's medication from $8.7 B Cerevel purchase ratings

.On the same time that some Parkinson's health condition drugs are being brought into question, AbbV...

Arch finalizes $3B-plus fund to promote biopharma startups

.On the heels of a $3 billion fund coming from Bain Capital Life Sciences, Arc Project Partners is a...

Orion to utilize Aitia's 'electronic twins' to discover brand-new cancer medications

.Finnish biotech Orion has actually spied prospective in Aitia's "electronic twin" technology to est...

Windtree's surprise med raises blood pressure in newest period 2 gain

.While Windtree Therapies has actually had a hard time to increase the financial roots needed to mak...

2 cancer cells biotechs merge, producing worldwide footprint

.OncoC4 is taking AcroImmune-- and also its internal professional production capabilities-- under it...

Amgen files first phase 3 gain for $400M chronic eczema medication

.Amgen has actually discussed (PDF) the first stage 3 information on its own $400 million chronic ec...

Biogen, UCB document period 3 lupus gain after stopping working earlier trial

.Biogen and UCB's bet one's bottom dollar improving right into stage 3 on the back of a broken study...

Aptadir wishes brand new RNA inhibitors can reverse tricky cancers cells

.Italian biotech Aptadir Rehabs has actually introduced with the commitment that its own pipeline of...

Wave surfs DMD success to regulators' doors, sending stock up

.Surge Life Sciences has satisfied its target in a Duchenne muscle dystrophy (DMD) study, installing...